{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:03:14Z","timestamp":1767211394042,"version":"3.48.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clinbiochem.2025.110988","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T05:22:30Z","timestamp":1755235350000},"page":"110988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Critical role of laboratory and multidisciplinary strategies in the early diagnosis of acquired haemophilia a for life-saving management"],"prefix":"10.1016","volume":"139","author":[{"given":"R.","family":"Belardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Emili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.G.","family":"Viola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Velocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Baldetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Minieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Picchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Morosetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-2252","authenticated-orcid":false,"given":"A.","family":"Terrinoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clinbiochem.2025.110988_b0005","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/MBC.0000000000000582","article-title":"Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry","volume":"27","author":"Kessler","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.clinbiochem.2025.110988_b0010","doi-asserted-by":"crossref","unstructured":"JY, Guillet B, Le Cam-Duchez V, Goudemand J, Levesque H, Group SS. Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hemophilie Acquise) registry. Haemophilia. 2013;19(4):564-70.","DOI":"10.1111\/hae.12138"},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.110988_b0015","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia a: Updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clinbiochem.2025.110988_b0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2147\/JBM.S284804","article-title":"Acquired Hemophilia a: Current Guidance and Experience from Clinical Practice","volume":"13","author":"Pishko","year":"2022","journal-title":"J Blood Med."},{"key":"10.1016\/j.clinbiochem.2025.110988_b0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2147\/JBM.S342077","article-title":"Acquired Haemophilia a: a Review of what we know","volume":"13","author":"Mingot-Castellano","year":"2022","journal-title":"J Blood Med."},{"issue":"10 Suppl","key":"10.1016\/j.clinbiochem.2025.110988_b0030","article-title":"Acquired factor VIII autoantibody inhibitors: current concepts and potential therapeutic strategies for the future","volume":"85","author":"Kessler","year":"2000","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110988_b0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/hae.13355","article-title":"Acquired haemophilia in cancer: a systematic and critical literature review","volume":"24","author":"Napolitano","year":"2018","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110988_b0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/107602960000600206","article-title":"Acquired hemophilia a in women postpartum: clinical manifestations, diagnosis, and treatment","volume":"6","author":"Michiels","year":"2000","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110988_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1651666","article-title":"Post-partum factor VIII inhibitors. a review of the literature with special reference to the value of steroid and immunosuppressive treatment","volume":"73","author":"Hauser","year":"1995","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110988_b0050","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia a in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre doctors' Organisation","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.clinbiochem.2025.110988_b0055","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/bloodadvances.2021004626","article-title":"Management of acquired hemophilia a: results from the spanish registry","volume":"5","author":"Mingot-Castellano","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.clinbiochem.2025.110988_b0060","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2147\/JBM.S219573","article-title":"Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC)","volume":"10","author":"Rajpurkar","year":"2019","journal-title":"J Blood Med."},{"issue":"Suppl 3","key":"10.1016\/j.clinbiochem.2025.110988_b0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2516.2010.02259.x","article-title":"Genetic markers in acquired haemophilia","volume":"16","author":"Oldenburg","year":"2010","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.110988_b0070","article-title":"A Case of acquired Hemophilia a following SARS-CoV-2 Infection","volume":"13","author":"Hafzah","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.clinbiochem.2025.110988_b0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.thromres.2022.12.010","article-title":"Association between SARS-CoV-2 infection or vaccination and acquired hemophilia a: a case report and literature update","volume":"222","author":"Franchini","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clinbiochem.2025.110988_b0080","doi-asserted-by":"crossref","unstructured":"Kamel K, Sardo Infirri S, Riddell A, Chowdary P, Batty P. Factor VIII Antibodies Demonstrate Type I or Type II Kinetics in Acquired Haemophilia A. Haemophilia. 2025.","DOI":"10.1111\/hae.15144"},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110988_b0085","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.2008.001743","article-title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia a","volume":"94","author":"Huth-Kuhne","year":"2009","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110988_b0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/hae.13424","article-title":"Laboratory testing for factor VIII and IX inhibitors in haemophilia: a review","volume":"24","author":"Miller","year":"2018","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110988_b0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/blood-2008-03-143586","article-title":"Acquired factor VIII inhibitors","volume":"112","author":"Franchini","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110988_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100065","article-title":"Performance characteristics of 5 numerical indexes in mixing test interpretation under coexistence of lupus anticoagulant and coagulation factor deficiency","volume":"7","author":"Matsuda","year":"2023","journal-title":"Res Pract Thromb Haemost."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110988_b0105","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/hae.13565","article-title":"Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients","volume":"24","author":"Rampersad","year":"2018","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.110988_b0110","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ajh.23723","article-title":"Chromogenic factor VIII activity assay","volume":"89","author":"Moser","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.110988_b0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-0034-1390004","article-title":"Laboratory diagnosis of acquired hemophilia a: limitations, consequences, and challenges","volume":"40","author":"Tiede","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110988_b0120","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s11239-021-02591-4","article-title":"Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient","volume":"53","author":"Jacobs","year":"2022","journal-title":"J. Thromb. Thrombolysis"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T13:31:08Z","timestamp":1766842268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025001171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":24,"alternative-id":["S0009912025001171"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110988","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical role of laboratory and multidisciplinary strategies in the early diagnosis of acquired haemophilia a for life-saving management","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110988"}}